Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase PncA
about
Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspectiveA balancing act: efflux/influx in mycobacterial drug resistancepncA mutations in clinical Mycobacterium tuberculosis isolates from KoreaSystematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolatesA Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-AnalysisSpecificity and Mechanism ofAcinetobacter baumaniiNicotinamidase: Implications for Activation of the Front-Line Tuberculosis Drug PyrazinamideCrystal Structure of the Pyrazinamidase of Mycobacterium tuberculosis: Insights into Natural and Acquired Resistance to PyrazinamidepncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, CanadaStudy of the structure-activity relationships for the pyrazinamidase (PncA) from Mycobacterium tuberculosisBase-calling algorithm with vocabulary (BCV) method for analyzing population sequencing chromatogramsMechanisms of Pyrazinamide Action and ResistanceSystematic analysis of pyrazinamide-resistant spontaneous mutants and clinical isolates of Mycobacterium tuberculosis.Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand.Peruvian and globally reported amino acid substitutions on the Mycobacterium tuberculosis pyrazinamidase suggest a conserved pattern of mutations associated to pyrazinamide resistance.Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in GeorgiaPhenotypic characterization of pncA mutants of Mycobacterium tuberculosis.Characteristics of pncA mutations in multidrug-resistant tuberculosis in Taiwan.Molecular epidemiological study of pyrazinamide-resistance in clinical isolates of mycobacterium tuberculosis from South India.Pyrazinamide resistance and pncA gene mutations in Mycobacterium tuberculosisTuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy.pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates in Portugal.Structure-Activity relationship in mutated pyrazinamidases from Mycobacterium tuberculosis.Widespread pyrazinamide-resistant Mycobacterium tuberculosis family in a low-incidence setting.Mechanistic analysis elucidating the relationship between Lys96 mutation in Mycobacterium tuberculosis pyrazinamidase enzyme and pyrazinamide susceptibility.Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance.Role of metal ions on the activity of Mycobacterium tuberculosis pyrazinamidase.Temperature-mediated heteroduplex analysis for detection of pncA mutations associated with pyrazinamide resistance and differentiation between Mycobacterium tuberculosis and Mycobacterium bovis by denaturing high- performance liquid chromatographyModes and modulations of antibiotic resistance gene expression.Correlation between pyrazinamide activity and pncA mutations in Mycobacterium tuberculosis isolates in Taiwan.Effect of pyrazinamidase activity on pyrazinamide resistance in Mycobacterium tuberculosisPyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses.Enhanced expression of the multidrug efflux pumps AcrAB and AcrEF associated with insertion element transposition in Escherichia coli mutants Selected with a fluoroquinolone.Mycobacterium smegmatis has two pyrazinamidase enzymes, PncA and pzaA.Characterization of multi-drug resistant Mycobacterium tuberculosis from immigrants residing in the USA using Ion Torrent full-gene sequencing.Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis in Brazil.A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide.Detection by denaturing gradient gel electrophoresis of pncA mutations associated with pyrazinamide resistance in Mycobacterium tuberculosis isolates from the United States-Mexico border regionInsight to pyrazinamide resistance in Mycobacterium tuberculosis by molecular docking.Spectrum of pncA mutations in multidrug-resistant Mycobacterium tuberculosis isolates obtained in Latvia.Kinetics and inhibition of nicotinamidase from Mycobacterium tuberculosis.
P2860
Q24535810-4047C8B9-D997-4E08-B364-306594C3D346Q24644870-522B3917-DA7E-408A-A4B8-90E5B563403CQ24800179-9F525EC6-39CD-4949-80EB-8DB480E3B01CQ27004697-A9E23B0A-B709-4840-B077-9441614F40E1Q27011264-19B837F1-0374-47BC-A73E-8A62A9AEC733Q27657995-87427C87-31D0-4C36-8036-3858DA2BEFBFQ27666806-6503265A-6DEE-44A7-88B1-9E5229A3400FQ28343917-F1F7A1DB-F583-4021-8DEE-75AE1B36A785Q28347549-CD4A1221-2948-4E0A-AFC6-03299BEDAC53Q28485329-B737BBAD-D2BA-4D3B-908E-172DA7C50728Q29304444-17F88D5B-3282-49DC-BF6D-FA27F4F29843Q30419570-D8C06007-EE13-4CF4-B918-F6D794CAF078Q33667486-8124304A-411C-4408-8260-7DB98610945FQ33752491-2B9D340E-570B-4CC0-B994-B97DEE4CEC9EQ33896434-8C24A07E-DD3F-4205-BB38-264D14077375Q33980394-E00DBCF8-6E21-47A6-B2AE-876ADB1FF103Q34017127-8031CC5C-C842-4F06-A228-69A03D45D719Q34061907-9262F30F-3B0C-4F91-94CD-7463FDFC47EBQ34757821-21AA5BA3-1B7C-491B-8756-E4B8090E4CCCQ34974987-5F6BE44F-83F8-48E4-A3F4-6E2FF23E9FCEQ35124816-AAAB547C-6BCD-461A-85AF-92218CCF4B12Q35127412-D7E06081-E651-448D-9291-B767DBD51DE4Q35155515-345F99A3-5C69-4645-A751-6BC11881382BQ35566384-707DB8E4-1EF6-42DE-B531-313F9DC98837Q35718261-2ECF4F6D-2EF0-4171-A511-DA68DF286544Q36080072-DB0C905A-D186-454E-A010-FD794355F237Q36597670-FC3475DE-D3B1-4E28-9253-2F4BBEA356C2Q36708242-534CE458-2BE8-484E-A6BF-91AA040129E3Q36880482-AC5CF338-9EDD-4C22-B3FF-ADCB484F305BQ37215691-D30E7416-9AF4-48AC-9848-72FF1B6C811FQ37902409-61159C82-9FDC-437F-8CF9-E3E0D2C8DBAAQ39477158-CD4ACF97-5118-4B2D-AF1C-E4AF577BCD24Q39500129-4F92CF87-DA54-47D9-BEA0-3351F754EB2EQ40294990-3BECB401-27D4-4767-86A8-B782B718343BQ40734443-E12D54F9-A2E2-4B01-87A4-EC526DC44218Q41701192-9DE26391-0090-482B-87D0-93D9F15F48DDQ42090699-34F21923-A09B-4588-BA9B-E2B5EEADEF9FQ42252197-322F123A-5EF1-4D37-9529-AD7CB127526DQ42409738-1101113F-BA59-46D4-9C31-C5F098A5C179Q42583812-440BC8FB-B386-49B5-916C-C6AEA740B13C
P2860
Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase PncA
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Characterization of new mutati ...... ity of the pyrazinamidase PncA
@ast
Characterization of new mutati ...... ity of the pyrazinamidase PncA
@en
type
label
Characterization of new mutati ...... ity of the pyrazinamidase PncA
@ast
Characterization of new mutati ...... ity of the pyrazinamidase PncA
@en
prefLabel
Characterization of new mutati ...... ity of the pyrazinamidase PncA
@ast
Characterization of new mutati ...... ity of the pyrazinamidase PncA
@en
P2093
P2860
P1476
Characterization of new mutati ...... ity of the pyrazinamidase PncA
@en
P2093
C Truffot-Pernot
N Lemaitre
W Sougakoff
P2860
P304
P407
P577
1999-07-01T00:00:00Z